- PLN3.19bn
- PLN4.07bn
- PLN13.64bn
Brief: Neuca Q1 Net Profit Up At 56.4 Mln Zlotys
Brief: Neuca AGM To Vote On FY 2023 Dividend Of 14.50 Zlotys/Shr
Brief: Neuca FY Net Profit Up At 146.3 Mln Zlotys
Brief: Neuca Q3 Net Profit Up At 45.1 Mln Zlotys
Brief: Neuca Acquires 51.26% Stake in PPH EWA
Brief: Ryvu Therapeutics Signs Two Deals With Clinscience
Brief: Neuca Launches Buyback Of Up To 1.1% Stake For 690 Zlotys/SHR
Brief: Neuca Sets Conditions For Buyback Programme
Brief: Neuca Q1 Net Profit Down At 47.3 Mln Zlotys
Brief: Neuca AGM To Vote On 2022 Dividend Of 13 Zlotys/Shr
Brief: Neuca FY 2022 Net Profit Down At 136.4 Mln Zlotys
Brief: Neuca Intends To Merge With Pretium Farm
Brief: Neuca Unit Signs Conditional Deal On Purchase Of Stake In Oncobay Clinical
Brief: Neuca Q3 Net Profit Down At 25.4 Mln Zlotys
Brief: Neuca Q2 Net Profit Up At 37.2 Mln Zlotys
Brief: Neuca Intends To Merge With Wholly-Owned Unit Aliant
Brief: Neuca Launches Buyback For Up To 2.13% Stake For 770 Zlotys/Shr
Brief: Neuca Plans To Buy Up To 5% Of Own Stake Under Buyback
Brief: Neuca AGM To Vote On 2021 Dividend Of 11.50 Zlotys/Shr